Latest News
Conference Coverage
Three days of beta-lactam beat clinically stable CAP
For some community-acquired pneumonia patients, short-term antibiotic therapy is a viable alternative to traditional longer courses.
Conference Coverage
How to choose between highly effective HBV therapies
The newest drug, tenofovir alafenamide, has the edge in its safety profile for treating chronic hepatitis B infection.
Conference Coverage
HBV birth dose predicts vaccine adherence
Infants who do not receive the hepatitis B vaccine birth dose are less likely to be up-to-date on recommended vaccines by 19 months, results from...
News
FDA warns of birth defect risks from dolutegravir
An FDA alert warns of serious neural tube birth defects occurring in babies born to women treated for HIV with dolutegravir early in pregnancy.
Conference Coverage
Myelin antibody predicts ADEM relapse
LOS ANGELES – Could results help to guide decisions on immunosuppressive treatment?
News from the FDA/CDC
FDA: PrEP indication updated to include adolescents at risk of HIV infection
The FDA has expand the Truvada indication to include adolescents weighing at least 35 kg who are at risk of HIV.
Conference Coverage
Simple QI intervention helped improve HPV vaccination rates
TORONTO - Acting on what had been missed opportunities in the past improved teen HPV vaccine rates.
Commentary
Two more and counting: Suicide in medical trainees
Dr. Michael F. Myers offers context for the latest discussions about physician suicides and calls on the medical community to act now.
Conference Coverage
Which infants with invasive bacterial infections are at risk for adverse outcomes?
TORONTO - Adverse outcomes are associated with prematurity, ill appearance, and bacterial meningitis.
News
FDA approves epoetin alfa biosimilar to treat anemia
This is the first product approved as biosimilar to epoetin alfa.
From the Journals
Persistent providers sway parents to accept HPV vaccination
Doctors who engage with parents can likely give HPV vaccine that day.